Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBD) are chronic conditions that primarily affect the gastrointestinal tract, with a complex pathogenesis; they are characterized by a significant heterogeneity of clinical presentations and of inflammatory pathways that sustain intestinal damage. After the introduction...
Main Authors: | Giuseppe Privitera, Daniela Pugliese, Gian Ludovico Rapaccini, Antonio Gasbarrini, Alessandro Armuzzi, Luisa Guidi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/4/853 |
Similar Items
-
Electrical and viscoelastic parameters of erythrocytes as predictors of exacerbation in inflammatory bowel diseases
by: M. V. Kruchinina, et al.
Published: (2021-10-01) -
Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients
by: Heba Adam, et al.
Published: (2020-04-01) -
Biological markers of disease activity in inflammatory bowel diseases
by: Edyta Szymanska, et al.
Published: (2023-07-01) -
Prevalence and predictors of medication non-adherence in children with inflammatory bowel disease in China: A cross-sectional study
by: Yuanyuan Wu, et al.
Published: (2022-12-01) -
Ischemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease
by: Seung Bum Lee, et al.
Published: (2024-01-01)